- Home
- IOVA vs GDEN Comparison
IOVA vs GDEN Comparison
Compare IOVA & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- GDEN
- Stock Information
- Founded
- IOVA 2007
- GDEN 1998
- Country
- IOVA United States
- GDEN United States
- Employees
- IOVA N/A
- GDEN N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- GDEN Services-Misc. Amusement & Recreation
- Sector
- IOVA Health Care
- GDEN Consumer Discretionary
- Exchange
- IOVA Nasdaq
- GDEN Nasdaq
- Market Cap
- IOVA 771.4M
- GDEN 725.6M
- IPO Year
- IOVA N/A
- GDEN 1999
- Fundamental
- Price
- IOVA $1.98
- GDEN $28.98
- Analyst Decision
- IOVA Buy
- GDEN Buy
- Analyst Count
- IOVA 10
- GDEN 6
- Target Price
- IOVA $12.22
- GDEN $37.00
- AVG Volume (30 Days)
- IOVA 11.2M
- GDEN 198.2K
- Earning Date
- IOVA 08-07-2025
- GDEN 08-07-2025
- Dividend Yield
- IOVA N/A
- GDEN 3.50%
- EPS Growth
- IOVA N/A
- GDEN N/A
- EPS
- IOVA N/A
- GDEN 0.39
- Revenue
- IOVA $212,679,000.00
- GDEN $653,614,000.00
- Revenue This Year
- IOVA $86.62
- GDEN $1.48
- Revenue Next Year
- IOVA $69.95
- GDEN $2.88
- P/E Ratio
- IOVA N/A
- GDEN $74.60
- Revenue Growth
- IOVA 11070.12
- GDEN N/A
- 52 Week Low
- IOVA $1.64
- GDEN $22.66
- 52 Week High
- IOVA $12.51
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- IOVA 43.44
- GDEN 59.86
- Support Level
- IOVA $1.95
- GDEN $26.81
- Resistance Level
- IOVA $2.47
- GDEN $28.15
- Average True Range (ATR)
- IOVA 0.15
- GDEN 0.80
- MACD
- IOVA 0.05
- GDEN 0.09
- Stochastic Oscillator
- IOVA 35.53
- GDEN 88.97
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.